Clinical application of circulating tumor cells in breast cancer: overview of the current interventional trials - Wikidata - thesis-toulmin - TriplyDB

Clinical application of circulating tumor cells in breast cancer: overview of the current interventional trials

Clinical application of circulating tumor cells in breast cancer: overview of the current interventional trials

http://www.wikidata.org/entity/Q26827936

about

Expression of stem cell and epithelial-mesenchymal transition markers in circulating tumor cells of breast cancer patients Minimal residual disease in breast cancer: an overview of circulating and disseminated tumour cells Evaluation and consequences of heterogeneity in the circulating tumor cell compartment Circulating tumor cells in breast cancer Dynamic changes in numbers and properties of circulating tumor cells and their potential applications Micrometastatic cancer cells in lymph nodes, bone marrow, and blood: Clinical significance and biologic implications AGO Recommendations for the Diagnosis and Treatment of Patients with Advanced and Metastatic Breast Cancer: Update 2015.Dissecting the Heterogeneity of Circulating Tumor Cells in Metastatic Breast Cancer: Going Far Beyond the Needle in the Haystack Potential Role of Circulating Tumor Cell Detection and Monitoring in Breast Cancer: A Review of Current Evidence Improving systemic breast cancer therapy: time to look beyond the primary tumour?Using circulating tumor cells to inform on prostate cancer biology and clinical utility Detection of circulating tumor DNA in early- and late-stage human malignancies ROCK inhibition promotes microtentacles that enhance reattachment of breast cancer cells Association of obesity and circulating adipose stromal cells among breast cancer survivors.Comparison of Circulating Tumour Cells and Circulating Cell-Free Epstein-Barr Virus DNA in Patients with Nasopharyngeal Carcinoma Undergoing Radiotherapy.PD-L1 expressing circulating tumour cells in head and neck cancers.International study on inter-reader variability for circulating tumor cells in breast cancer A novel flow cytometry-based cell capture platform for the detection, capture and molecular characterization of rare tumor cells in blood.Cancer gene panel analysis of cultured circulating tumor cells and primary tumor tissue from patients with breast cancer.The HER2 phenotype of circulating tumor cells in HER2-positive early breast cancer: A translational research project of a prospective randomized phase III trial.Single cell mutational analysis of PIK3CA in circulating tumor cells and metastases in breast cancer reveals heterogeneity, discordance, and mutation persistence in cultured disseminated tumor cells from bone marrow.Can biomarker assessment on circulating tumor cells help direct therapy in metastatic breast cancer?Development of circulating tumor cell-endocrine therapy index in patients with hormone receptor-positive breast cancer.Circulating tumor cells predict survival in early average-to-high risk breast cancer patients.Microscale magnetic field modulation for enhanced capture and distribution of rare circulating tumor cells CTC enumeration and characterization: moving toward personalized medicine.Microenvironmental Influences on Metastasis Suppressor Expression and Function during a Metastatic Cell's Journey.Site-specific metabolic phenotypes in metastatic breast cancer.A Phase II study of bevacizumab in combination with trastuzumab and docetaxel in HER2 positive metastatic breast cancer.Markers for the identification of late breast cancer recurrence.New Approach for Interpreting Changes in Circulating Tumour Cells (CTC) for Evaluation of Treatment Effect in Metastatic Breast Cancer.Label-free detection of rare cell in human blood using gold nano slit surface plasmon resonance.Prognostic Relevance of Circulating Tumor Cells in Molecular Subtypes of Breast Cancer.A novel method for downstream characterization of breast cancer circulating tumor cells following CellSearch isolation Do circulating tumor cells, exosomes, and circulating tumor nucleic acids have clinical utility? A report of the association for molecular pathology Prognostic value of circulating tumor cells in patients with squamous cell carcinoma of the head and neck: a systematic review and meta-analysis.In vitro detection of circulating tumor cells compared by the CytoTrack and CellSearch methods.Real-time HER2 status detected on circulating tumor cells predicts different outcomes of anti-HER2 therapy in histologically HER2-positive metastatic breast cancer patients A FISH-based method for assessment of HER-2 amplification status in breast cancer circulating tumor cells following CellSearch isolation Blood-Based Analysis of Circulating Cell-Free DNA and Tumor Cells for Early Cancer Detection

P2860

Q21284707-81DD1222-6BF0-4396-BC05-63B899B13F0A Q26748850-7A7541C9-BCD5-4789-BB54-DA8A30122AB5 Q26765357-480E828A-1B35-4F89-9FF2-F80443EC4649 Q26774808-272BC3FA-3CBC-40D5-B27A-989D7A9CB91A Q26853569-1A23BF2A-F233-4569-AAAB-8F479A63ACBF Q26996059-F41521BD-F2D4-434B-A70B-29869CAEA082 Q27343148-4D2ED051-8CAD-49D5-AA2E-D60FB3D7D728 Q28067549-4EC5358D-FB48-4EB1-82A9-E6532C8618C0 Q28075850-90BAAFDA-8DE9-415E-A8FE-1B4FFF49DEB8 Q28078275-53E0C269-5299-400A-B82B-9F9944259246 Q28083261-7903CAAA-82F5-4DCA-9088-8C41123885DA Q29615778-FB2E232A-9FF5-438C-B144-AE5D68A3032F Q30408828-21DB30F1-08EB-4B32-8DB0-775F3C0316F1 Q33591042-5DEEF2E6-38E6-4C82-B1EC-4C320F970A16 Q33685029-FDBB66F6-616D-4A92-BA7B-C3482D8C9DCA Q33697273-E7B431E3-4CCF-47C8-8A68-28E287128B09 Q33738688-C02B0574-7B48-4F01-92EB-A989E29063C2 Q33741201-4A52C52A-527E-4E72-86DE-A2D9713697CA Q33751043-2B321A2B-8BB7-4C39-BF52-E8CE9B245271 Q33769034-A5742B03-E8A2-43B8-B14F-E8CE27DBE6DD Q33806957-258ECFD5-391C-499D-9D74-11E2E6CEABEF Q33820233-8ED54BB6-0F10-447C-A6F4-38D013249C74 Q33917455-FD5F5B0B-8983-4CF8-A8B6-35D797D4DB57 Q33958981-97FA8A7D-7F44-4551-9CF9-555511DEA1DB Q34465467-12AB112A-1228-4FCA-ADD7-DE56D47AEDFD Q34577724-399686D8-E4AD-4545-B28D-B83C20085DA6 Q34766640-80FD5444-9C11-4530-96F9-0D71741B92B2 Q34788659-7259B224-7111-4351-84A8-554FB1815671 Q35001280-0CD62C5F-770F-448F-9620-1D9653DEE5DF Q35018949-B145FABA-5190-4048-B7D7-2734CDD2A826 Q35028760-D7901401-2623-48F0-90F2-28260A8DE2DC Q35255260-6E17CD5C-606B-4DF5-B0C8-6ADCE5F801A5 Q35427994-3342FE48-0B57-499A-B796-8C4B34C3F69C Q35538013-C2B849EF-45FF-4441-BDE1-CF888C7A34A5 Q35543094-F4D1D681-A490-486E-BBC2-BA16C5EB3050 Q35610277-41B0BDF3-2B7F-4D69-A29C-ED69DC7E26F2 Q35929366-8C6B44C2-7A5D-4ADD-A87D-B3E58162C349 Q36085254-7E4E6033-171A-4EDA-8761-7FBDC7365BA2 Q36206190-C6DB764C-3269-4C9B-B000-4A92458DC901 Q36233833-B755207D-CFF2-40A0-8D16-8E545C55449B

P2860

Clinical application of circulating tumor cells in breast cancer: overview of the current interventional trials

http://www.wikidata.org/entity/Q26827936

description

2013 nî lūn-bûn

@nan

2013 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Clinical application of circul ...... current interventional trials

@ast

Clinical application of circul ...... current interventional trials

@en

Clinical application of circul ...... current interventional trials

@nl

type

label

Clinical application of circul ...... current interventional trials

@ast

Clinical application of circul ...... current interventional trials

@en

Clinical application of circul ...... current interventional trials

@nl

prefLabel

Clinical application of circul ...... current interventional trials

@ast

Clinical application of circul ...... current interventional trials

@en

Clinical application of circul ...... current interventional trials

@nl

P1433

Q26827936-54BCA819-7189-40F2-9946-D84EEFC5B1EF

P1476

Q26827936-6FC92E53-717B-4A99-ACF5-1A7836E2F5A4

P2093

Q26827936-1E998C40-E5F9-4D31-A7E5-102C8712F60B

Q26827936-25BD7E72-2EB4-40E1-812B-9B5E43EAAF74

Q26827936-26F2E2CE-71DC-4DA7-8C2C-ECE3A26F6DA1

Q26827936-3B1F1C3A-2486-46FE-A382-4B03BE4A63D0

Q26827936-93072A41-B072-47AA-862E-CAC82A2EC2D9

Q26827936-B1E96599-6248-40F9-9E7C-811B59952861

Q26827936-B7B7A87B-C43E-4A4E-B13A-DA721EA4F7BB

Q26827936-D863BBE3-C237-4E8E-BBCD-4338E65C97D4

Q26827936-DF12D320-907C-424E-A3A4-B6661207C992

P2860

Q26827936-1BB1778B-F38D-4D53-B471-73B176C72BAF

Q26827936-21EA3F2B-6BB3-45EB-B4EA-534706CBF3B1

Q26827936-3457C5AD-1185-40F2-A409-DDFDE47A974F

Q26827936-520A0CDE-2E03-4450-BD4A-D1C21B709E95

Q26827936-56645244-C21B-4B5F-854E-B82A217F2107

Q26827936-6CEA48FA-208C-41AC-8426-2A20CCD4001E

Q26827936-77F28CD4-F1AC-41D2-AEE3-0C20C5B1472F

Q26827936-7D994A24-2156-4625-B079-1693FA749C75

Q26827936-828AC189-3C69-4B93-BFEC-75B6B088E709

Q26827936-89931B7F-02F1-4934-A13F-B7F05F993C07

P2888

Q26827936-C778BB97-A728-436C-BCF3-672F3625619A

P304

Q26827936-D1DAA157-04CF-49DA-AFC6-39BA1B432E39

P31

Q26827936-0785A784-06E8-4534-BD47-123380890696

Q26827936-E47B48BC-A075-40D1-893F-2296E3623557

P3181

Q26827936-402170D1-CA62-44B9-ACB2-BE28598D5475

P356

Q26827936-43FC5816-207C-4DE3-8117-F1C768F07D0C

P407

Q26827936-0727141D-0027-4C34-A7D3-23C02EA9BC24

P433

Q26827936-30025A59-430D-45EE-A83D-E1715E58508F

P478

Q26827936-3B358794-E869-46F3-BABF-47E8AD1772E7

P50

Q26827936-02EB7809-9429-4823-A40D-BAC477E79456

Q26827936-1FA6D141-B370-4A75-9A2F-B0B985589BAD

Q26827936-AAB00251-3F43-4FB3-B578-86B55119E449

P577

Q26827936-0F2C5F52-8B02-4174-894C-635A40CF9137

Q26827936-DD9E7FBF-70F8-4BDD-B73A-AC75A9BEFDE0

P5875

Q26827936-3A0A54E1-42B1-4E99-8A80-93C938FC14C0

P6179

Q26827936-2729DF3D-6569-44D6-B49D-F80AFFE92693

P698

Q26827936-B73DA4E8-08D0-4764-A704-03585FCDC091

P921

Q26827936-391DA041-B20B-4FBC-B66F-CFF75F92AF9B

Q26827936-5670C5F1-F34F-40D8-94AE-5AC2DC2C8A6F

Q26827936-E6CECC33-2EF0-4A39-9C65-B808EBD90DF0

P932

Q26827936-266556EC-B221-41AD-9883-44835690FE13

P3181

P356

S10555-012-9398-0

P1433

Cancer and Metastasis Reviews

P1476

Clinical application of circul ...... current interventional trials

@en

P2093

Carlo Messina

http://www.w3.org/2001/XMLSchema#string

Costanza Paoletti

http://www.w3.org/2001/XMLSchema#string

Daniel F. Hayes

http://www.w3.org/2001/XMLSchema#string

Jean-Yves Pierga

http://www.w3.org/2001/XMLSchema#string

Jeffrey B. Smerage

http://www.w3.org/2001/XMLSchema#string

Martine Piccart

http://www.w3.org/2001/XMLSchema#string

Michail Ignatiadis

http://www.w3.org/2001/XMLSchema#string

Volkmar Müller

http://www.w3.org/2001/XMLSchema#string

Wolfgang Janni

http://www.w3.org/2001/XMLSchema#string

P2860

HER-2 gene amplification can be acquired as breast cancer progresses

New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)

Circulating tumor cells, disease progression, and survival in metastatic breast cancer

Prognosis of women with metastatic breast cancer by HER2 status and trastuzumab treatment: an institutional-based review

Development of circulating tumor cell-endocrine therapy index in patients with hormone receptor-positive breast cancer.

Four-year follow-up of trastuzumab plus adjuvant chemotherapy for operable human epidermal growth factor receptor 2-positive breast cancer: joint analysis of data from NCCTG N9831 and NSABP B-31.

Prospective analysis of the impact of VEGF-A gene polymorphisms on the pharmacodynamics of bevacizumab-based therapy in metastatic breast cancer patients

Assessment of circulating tumor cells and serum markers for progression-free survival prediction in metastatic breast cancer: a prospective observational study.

Determination of HER2 status using both serum HER2 levels and circulating tumor cells in patients with recurrent breast cancer whose primary tumor was HER2 negative or of unknown HER2 status

Detection and HER2 expression of circulating tumor cells: prospective monitoring in breast cancer patients treated in the neoadjuvant GeparQuattro trial.

P2888

s10555-012-9398-0

P304

179-88

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

1588842

http://www.w3.org/2001/XMLSchema#string

P356

10.1007/S10555-012-9398-0

http://www.w3.org/2001/XMLSchema#string

P407

P433

1-2

http://www.w3.org/2001/XMLSchema#string

P478

32

http://www.w3.org/2001/XMLSchema#string

P50

Catherine Alix-Panabières

François-Clément Bidard

P577

2013-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

232918069

http://www.w3.org/2001/XMLSchema#string

P6179

1053144083

http://www.w3.org/2001/XMLSchema#string

P698

23129208

http://www.w3.org/2001/XMLSchema#string

P921

breast neoplasm

P932

3655223

http://www.w3.org/2001/XMLSchema#string